Clinical Trial Update: Mucosal Gene Expression Defects in IBD

View source ↗

Summary

A completed KU Leuven clinical trial investigating mucosal gene expression defects in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: KU Leuven | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED